Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Simon Mark Kremer has worked on the following 165 EPO patent applications which have been published in the last five years:

EP11709836

FULL COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE

IPC classification:
C12Q 1/68
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11796068

MODIFIED STEM-LOOP OLIGONUCLEOTIDE MEDIATED REVERSE TRANSCRIPTION AND BASE-SPACING CONSTRAINED QUANTITATIVE PCR

IPC classification:
C12Q 1/68
Applicant:
National University of Singapore
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11809726

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/44, C12Q 1/60, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11809724

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/42, C12Q 1/44, C12Q 1/60, G01N 33/48, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11763802

FILAMENTOUS FUNGI HAVING AN ALTERED VISCOSITY PHENOTYPE

IPC classification:
C07K 14/37, C12N 15/31, C12R 1/885
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11774073

METHOD TO INHIBIT RECRUITMENT OF MONOCYTES AND MACROPHAGES BY AN ICAM-3 INHIBITOR

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/28
Applicant:
Aston University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11807349

COMPOSITIONS AND METHODS FOR INCREASING POULTRY HATCHABILITY AND EARLY PERFORMANCE

IPC classification:
A01K 45/00, A61K 31/718, A61K 38/17, C08H 1/04, C08L 3/02, C08L 89/00
Applicant:
The Board of Trustees of The University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12705589

OMEGA 3 FATTY ACID DIAGNIOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE (CVD)

IPC classification:
A61K 31/202, A61K 45/06, A61P 9/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12705591

STATIN AND OMEGA 3 FATTY ACIDS (EPA, DHA AND DPA) FOR USE IN CARDIOVASCULAR DISEASES

IPC classification:
A61K 9/00, A61K 31/202, A61K 31/40, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707420

OMEGA 3 FORMULATIONS COMPRISING EPA, DHA AND DPA FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE

IPC classification:
A61K 31/202, A61K 45/06, A61P 9/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12705590

A FORMULATIONS COMPRISING OMEGA 3 FATTY ACIDS AND AN ANTI OBESITY AGENT FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS

IPC classification:
A61K 31/202, A61K 31/454, A61K 45/06, A61P 3/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12705588

CHOLESTEROL ABSORPTION INHIBITOR (AZETIDINONE) AND OMEGA 3 FATTY ACIDS (EPA, DHA, DPA) FOR THE REDUCTION OF CHOLESTEROL AND FOR THE REDUCTION OF CARDIOVASCULAR EVENTS

IPC classification:
A61K 31/202, A61K 31/397, A61K 45/06, A61P 9/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12708466

KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION

IPC classification:
C12Q 1/68
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12752957

METHOD FOR QUANTIFYING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 2, AND REAGENT KIT FOR THE METHOD

IPC classification:
C12Q 1/44, C12Q 1/60
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12716642

COMPOSITIONS

IPC classification:
C07K 14/37, C11D 3/38, C11D 3/386, C12N 9/20
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12723902

THERAPEUTIC COMPOUNDS

IPC classification:
A61K 31/192, A61K 31/198, A61P 31/00, A61P 31/04, A61P 31/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774474

CELL-SYNTHESIZED PARTICLES

IPC classification:
C12N 5/00, C12N 5/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774564

MANUAL BREAST PUMP

IPC classification:
A61M 1/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12725174

SINGLE PH PROCESS FOR STARCH LIQUEFACTION AND SACCHARIFICATION FOR HIGH-DENSITY GLUCOSE SYRUPS

IPC classification:
C12N 9/24, C12P 19/20
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12781636

MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF

IPC classification:
A61K 31/00, A61K 38/00, A61K 39/02, A61K 39/39, A61P 37/02, A61P 37/04
Applicant:
Children's Medical Center Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12782582

MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS

IPC classification:
A61K 31/00, A61K 38/00, A61K 39/085, A61P 31/00, A61P 37/02, A61P 37/04
Applicant:
Children's Medical Center Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11840505

METHOD FOR QUANTIFICATION OF REMNANT-LIKE LIPOPROTEIN CHOLESTEROL AND KIT FOR SAME

IPC classification:
C12Q 1/28, C12Q 1/30, C12Q 1/44, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12750896

ACTIVE-FEEDBACK POSITIONAL DRIFT CORRECTION IN A MICROSCOPE IMAGE USING A FIDUCIARY ELEMENT HELD ON A NANOPOSITIONING STAGE

IPC classification:
G02B 21/00, G02B 21/26, G02B 21/34, G02B 21/36
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12779776

METHODS OF DEVELOPING A PROGNOSIS FOR PANCREATIC CANCER AND PREDICTING RESPONSIVENESS TO CANCER THERAPEUTICS

IPC classification:
A61K 39/395
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP10848606

TREATING ALLERGY WITH DETOXIFIED E. COLI HEAT-LABILE ENTEROTOXIN

IPC classification:
A61K 38/16, A61K 39/00, A61K 39/108, A61P 27/14, C07K 14/245, C12N 1/21, C12N 15/09, C12N 15/31
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The patent has been granted
EP12756593

PEPTIDE NANOPARTICLES AND USES THEREOF

IPC classification:
C07K 7/06, C07K 7/08, C07K 14/00
Applicant:
President and Fellows of Harvard College
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12828679

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/497
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12831538

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/498, C07D 241/36
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12847165

METHODS AND COMPOSITIONS FOR X-RAY INDUCED RELEASE FROM PH SENSITIVE LIPOSOMES

IPC classification:
A61K 9/127
Applicant:
The Board of Trustees of The University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12801442

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

IPC classification:
A61K 31/155, A61K 31/38, A61K 31/41, A61K 31/4436, A61K 31/495, A61K 31/4965, A61K 31/4985, A61K 31/4995, A61K 31/5377, A61K 31/554, A61K 31/7042, A61K 45/06, A61P 1/16
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12853600

PROTEIN INHIBITORS TO COMPLEMENT AND VEGF PATHWAYS AND METHODS OF USE THEREOF

IPC classification:
A61K 38/17, A61P 27/02, A61P 35/00, C07K 14/71, C07K 19/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12854380

METHODS AND COMPOSITIONS FOR INCREASING ARYLSULFATASE A ACTIVITY IN THE CNS

IPC classification:
A61K 39/395, A61P 25/00, A61P 25/16, A61P 25/28
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12861144

METHODS OF IDENTIFYING AND USING MDM2 INHIBITORS

IPC classification:
A61K 31/40, A61K 31/675, A61K 39/395, G01N 33/53
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12809843

CALCIUM PHOSPHATE MATERIAL

IPC classification:
C01B 25/32
Applicant:
The University Court of The University of Aberdeen
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12806851

VARIANT ALPHA-AMYLASES AND METHODS OF USE, THEREOF

IPC classification:
C12N 5/10, C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12854214

ANTI-CEACAM1 RECOMBINANT ANTIBODIES FOR CANCER THERAPY

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 5/10, C12N 15/13, C12N 15/63, G01N 33/53
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11878823

FUSED TETRA OR PENTA-CYCLIC PYRIDOPHTHALAZINONES AS PARP INHIBITORS

IPC classification:
A61K 31/50, A61P 35/00, C07D 471/06, C07D 491/06, C07D 495/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12862641

REAGENTS AND METHODS FOR AUTOLIGATION CHAIN REACTION

IPC classification:
C12Q 1/68
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13736256

HOST CELLS WITH ARTIFICIAL ENDOSYMBIONTS

IPC classification:
A61K 35/74
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12775962

METHODS OF TREATING HEMOGLOBINOPATHIES

IPC classification:
A61K 31/00, A61K 31/18, A61P 7/00
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13740877

METHOD FOR QUANTIFYING CHOLESTEROL IN HIGH DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/26, C12Q 1/42, C12Q 1/60, G01N 33/48, G01N 33/50, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13740865

METHOD FOR CULTIVATION OF MONARDA FISTULOSA

IPC classification:
A01C 7/00, C12P 7/22
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13703871

EYE MASSAGE DEVICE

IPC classification:
A61F 9/00, A61H 7/00, A61H 23/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12761364

FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES

IPC classification:
G01N 33/50, G01N 33/543, G01N 33/58
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12741863

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/585, A61P 35/00, C07J 19/00, C07J 41/00, C07J 43/00, C07J 71/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11866898

DRINK CONTAINER

IPC classification:
A47G 19/22, B65D 51/16, B65D 51/24
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12753875

A METHOD FOR TREATING OBESITY WITH ANTI-OBESITY FORMULATIONS AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS

IPC classification:
A61K 31/202, A61K 31/454, A61K 45/06, A61P 3/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753303

AZETIDINONE CHOLESTEROL ABSORPTION INHIBITOR (EZETIMIBE) AND OMEGA 3 FATTY ACIDS (EPA, DHA, DPA) FOR THE REDUCTION OF CHOLESTEROL AND FOR THE REDUCTION OF CARDIOVASCULAR EVENTS

IPC classification:
A61K 31/202, A61K 31/397, A61K 45/06, A61P 9/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753302

OMEGA 3 FATTY ACID FOR USE AS A PRESCRIPTION MEDICAL FOOD AND OMEGA 3 FATTY ACID DIAGNIOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF CARDIOVASCULAR PATIENTS WITH CARDIOVASCULAR DISEASE (CVD) WHO ARE DEFICIENT IN BLOOD EPA AND DHA LEVELS

IPC classification:
A61K 31/202, A61K 45/06, A61P 9/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12750967

STATIN AND OMEGA 3 FATTY ACIDS FOR REDUCTION OF APOLIPOPROTEIN-B LEVELS

IPC classification:
A61K 9/00, A61K 9/48, A61K 31/202, A61K 31/40, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753874

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

IPC classification:
A61K 9/48, A61K 31/202, A61K 45/06, A61P 9/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13755202

RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING

IPC classification:
C12Q 1/02, C12Q 1/04, C12Q 1/18
Applicant:
President and Fellows of Harvard College
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764561

GROWTH DIFFERENTIATION FACTOR (GDF) FOR TREATMENT OF DIASTOLIC HEART FAILURE

IPC classification:
A61K 39/00, A61P 9/00, C07K 14/475
Applicant:
President and Fellows of Harvard College
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764026

TISSUE-ENGINEERED HEART VALVE FOR TRANSCATHETER REPAIR

IPC classification:
A61F 2/04, C12M 1/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13769843

IMMUNOLOGICAL ANALYSIS METHOD AND REAGENT

IPC classification:
G01N 33/531, G01N 33/543
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12815062

SELF-RESONATING SOUND EMITTING SPEAKER AND METHOD FOR INSTALLING SELF-RESONATING SOUND EMITTING SPEAKER

IPC classification:
H04R 1/02, H04R 5/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13777616

METHOD FOR REMOVAL OF TRIGLYCERIDES IN LIPOPROTEINS OTHER THAN LOW-DENSITY LIPOPROTEINS

IPC classification:
C12Q 1/26, C12Q 1/44, C12Q 1/48, C12Q 1/61, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13772046

METHODS OF USING CERIUM OXIDE NANOPARTICLES TO MITIGATE OR PROTECT AGAINST RADIATION INJURY

IPC classification:
A61K 9/14
Applicant:
Duke University
Applicant:
University of Central Florida Research Foundation Inc
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12833985

CERTAIN CHEMICAL ENTITES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/498, A61P 35/00, C07D 241/42
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14171013

Antibodies and immunoconjugates and uses therefor

IPC classification:
A61K 39/00, A61K 39/395, A61K 47/48, A61K 49/00, A61K 51/10, A61P 35/00, C07K 16/30, C12N 5/10, C12N 15/13
Applicant:
Genentech, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13787745

METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE

IPC classification:
A61P 35/00, C12Q 1/68
Applicant:
The General Hospital Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13784674

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A01N 45/00
Applicant:
Neupharma, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13787726

METHODS OF TREATING CANCER USING ANGIOGENIN OR AN ANGIOGENIN AGONIST

IPC classification:
A61K 38/17, A61P 35/00, C07K 14/515
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13734185

IL-6 BINDING MOLECULES

IPC classification:
A61K 39/395, C07K 16/24
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13729864

ALPHA-AMYLASE VARIANTS DERIVED FROM THE ALPHA AMYLASE OF CYTOPHAGA SP.AMYLASE (CSPAMY2).

IPC classification:
C12N 9/26
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13712656

HGH-XTEN FUSION PROTEIN AND ITS USE IN THE TREATMENT OF GROWTH HORMONE DEFICIENCY

IPC classification:
A61K 38/27, A61K 47/42, A61P 5/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14189047

Unstructured recombinant polymers and uses thereof

IPC classification:
G01N 33/53, G01N 33/567
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13807181

SUBSTITUTED TROPOLONE DERIVATIVES AND METHODS OF USE

IPC classification:
C07C 245/10, C07D 307/46, C07D 333/22, C07D 333/74
Applicant:
University of Connecticut
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13806348

PURIFICATION OF 3-HYDROXYPROPIONIC ACID FROM CRUDE CELL BROTH AND DEHYDRATION TO ACRYLIC ACID

IPC classification:
C07C 51/377
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11769186

THERMOPLASTIC COMPOSITION FORMED FROM POLYLACTIC ACID AND ELASTOMERIC GRAFT COPOLYMER

IPC classification:
C08G 81/02, C08L 33/08, C08L 67/04
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13813314

DRUG INFUSION WITH PRESSURE SENSING AND NON-CONTINUOUS FLOW WITH INDENTIFICATION OF AND INJECTION INTO FLUID-FILLED ANATOMIC SPACES

IPC classification:
A61M 5/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11769187

ELASTOMERS CROSSLINKED BY POLYLACTIC ACID

IPC classification:
C08G 81/02
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13822806

INDWELLING URINARY CATHETER

IPC classification:
A61M 25/01, A61M 25/04, A61M 25/14
Applicant:
University of Utah Research Foundation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13822996

METHOD OF TREATING OPTIC NERVE DAMAGE, OPHTHALMIC ISCHEMIA OR OPHTHALMIC REPERFUSION INJURY

IPC classification:
A61K 9/06, A61K 38/08, A61P 27/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13836097

METHODS OF EXPANDING AND ASSESSING B CELLS AND USING EXPANDED B CELLS TO TREAT DISEASE

IPC classification:
C12N 5/0781
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11878035

MILL

IPC classification:
B02C 13/14, B02C 13/18, B02C 13/28, B02C 13/286, B02C 13/288, B02C 19/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11821345

METHOD FOR FORMING SEAT CUSHIONS

IPC classification:
A47C 27/12, B68G 11/06, D04H 3/005
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13838131

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/47, A61P 35/00
Applicant:
Neupharma, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13842707

ROLLING MAT

IPC classification:
A23L 1/10, A47J 43/20
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13844402

METHOD FOR MEASURING HEMAGGLUTININ FROM INFLUENZA VIRUS

IPC classification:
G01N 33/53, G01N 33/531, G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14198178

Compositions for increasing polypeptide stability and activity, and related methods

IPC classification:
C07K 14/00, C07K 19/00, C12N 9/00, C12N 9/12, C12N 9/14, C12N 9/22, C12N 9/50, C12N 9/78, C12N 9/96
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11828444

MOISTURE METER

IPC classification:
A61B 5/00, A61B 5/0408, A61B 5/0478, A61B 5/053
Applicant:
Terumo Kabushiki Kaisha
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13838290

NOVEL STRAINS OF BREVIBACILLUS LATEROSPORUS AS BIOCONTROL AGENTS AGAINST PLANT PESTS, PARTICULARLY LEPIDOPTERA AND DIPTERA

IPC classification:
A01N 63/00, C12N 1/20
Applicant:
Lincoln University (NZ)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13850423

NOVEL MUCOSAL ADJUVANTS AND DELIVERY SYSTEMS

IPC classification:
A61K 31/715, A61K 31/716, C07H 15/04
Applicant:
The Board of Trustees of The University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13852971

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/498, A61K 31/5377, C07D 403/04
Applicant:
Neupharma, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13854549

COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM

IPC classification:
A61K 31/04, A61K 31/195, A61K 38/54
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13854686

ONCOLYTIC HSV1 VECTORS AND METHODS OF USING THE SAME

IPC classification:
A61K 35/76, A61K 48/00, A61P 35/00, C12N 7/00, C12N 15/86
Applicant:
Ohio State Innovation Foundation
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13856451

TROPHIC HORMONE FUSION PROTEIN, PREPARATION METHOD AND APPLICATION THEREOF

IPC classification:
A61K 38/24, A61K 47/48, A61P 15/08, C07K 14/59, C07K 19/00, C12N 15/16, C12N 15/62, C12N 15/63
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11828445

MOISTURE METER

IPC classification:
A61B 5/00, A61B 5/01, A61B 5/1455
Applicant:
Terumo Kabushiki Kaisha
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815298

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C11D 3/386, C12N 9/42, C12N 15/80, C12P 19/14
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13815294

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13815297

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C11D 3/386, C12N 9/42, C12N 15/80, C12P 19/14
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13815295

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C12N 9/24, C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815296

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15155831

Methods for treating multiple sclerosis using antisense oligonucleotides

IPC classification:
A61K 31/7088, C07H 21/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14735434

MICROBIOME MODULATION INDEX

IPC classification:
A61K 35/74, C12Q 1/02, C12Q 1/68
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14704192

TOBACCO INBRED PLANTS K326 SRC, CMS K326 SRC, K346 SRC, CMS K346 SRC, NC1562-1 SRC, NCTG-61 SRC, CMS NCTG-61 SRC AND HYBRID NC196 SRC

IPC classification:
A01H 5/12, C12N 9/02, C12N 9/10
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13870762

AGENTS FOR TREATING TUMOURS, USE AND METHOD THEREOF

IPC classification:
A61K 39/395, A61P 35/00
Agent:
Weickmann & Weickmann PartmbB
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14740732

TREATING PULMONARY CONDITIONS

IPC classification:
A61K 31/075, A61K 31/195, A61K 38/43
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14705566

AGENTS WHICH INDUCE LYMPHANGIOGENESIS FOR USE IN THE TREATMENT OF CYSTIC KIDNEY DISEASE

IPC classification:
A61K 38/17, A61K 38/18, A61K 48/00, A61P 13/12
Applicant:
UCL Business plc
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14751914

COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA OR LIMITING EIMERIA INFECTION

IPC classification:
A61K 39/002, A61K 39/012, C12N 15/00
Applicant:
The Board of Trustees of The University of Arkansas
Applicant:
Texas A&M University System (TAMU)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14714825

TOBACCO INBRED AND HYBRID PLANTS AND USES THEREOF

IPC classification:
A01H 5/12, C12N 9/10, C12N 15/82
Applicant:
North Carolina State University
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14760175

COMPOSITIONS AND METHODS FOR BACTERIAL DELIVERY OF POLYPEPTIDES

IPC classification:
A61K 35/74
Applicant:
President and Fellows of Harvard College
Applicant:
The General Hospital Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14775740

MICROBIAL ECOLOGY SHIFT ASSAY

IPC classification:
G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14770824

TREATMENT OF PETS WITH SIRTUIN ACTIVATORS

IPC classification:
A61K 31/00, A61K 31/198, A61P 3/08
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14768984

LEUCINE AND NICOTINIC ACID REDUCES LIPID LEVELS

IPC classification:
A61K 31/51, A61P 3/10, C12P 13/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14779908

COMPOSITIONS COMPRISING THIENOPYRIMIDINE AND THIENOPYRIDINE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/519
Applicant:
The Regents of the University of Michigan
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14769698

COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO ENTERIC PATHOGENS

IPC classification:
A61K 35/74
Applicant:
The Board of Trustees of The University of Arkansas
Applicant:
Texas A&M University System (TAMU)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14780175

TREATMENT OF PEDIATRIC GROWTH HORMONE DEFICIENCY WITH HUMAN GROWTH HORMONE ANALOGUES

IPC classification:
A61K 38/16, A61K 38/27
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14767946

COMPOSITIONS, METHODS, AND KITS FOR TREATMENT OF PETS

IPC classification:
A23K 50/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14785279

COMPOSITIONS AND METHODS FOR MODULATION AND DETECTION OF IMMUNE AND INFLAMMATORY RESPONSES

IPC classification:
A61K 39/00, G01N 33/554, G01N 33/569
Applicant:
University of Connecticut
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14788064

SUBSTITUTED5-(3,5-DIMETHYLISOXAZOL-4-YL)INDOLINE-2-ONES

IPC classification:
A61K 31/41, A61P 35/00, C07D 209/04, C07D 413/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15161198

THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES

IPC classification:
A61K 31/5415, A61P 25/28
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14786060

METHODS AND MATERIALS FOR ENCAPSULATING PROTEINS

IPC classification:
C07K 14/195, C12N 15/31, C12N 15/62, C12N 15/82
Applicant:
Agresearch Limited
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15176673

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

IPC classification:
A61K 9/02, A61K 31/155, A61K 31/16, A61K 31/18, A61K 31/19, A61K 31/191, A61K 31/216, A61K 31/38, A61K 31/40, A61K 31/42, A61K 31/452, A61K 31/454, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11729442

BONE GRAFT SYSTEM

IPC classification:
A61L 27/46, A61L 27/52
Applicant:
The University Court of The University of Aberdeen
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15175407

METHODS AND COMPOSITIONS FOR INCREASING ALPHA-L-IDURONIDASE ACTIVITY IN THE CNS

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/40, C07K 16/46, C12N 9/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14717867

COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION

IPC classification:
A61K 38/46, A61K 38/47, A61K 38/48, A61K 47/06, C12N 9/26, A23L 33/10, A23L 33/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15192531

COMPUTER CONTROLLED DRUG DELIVERY SYSTEM WITH DYNAMIC PRESSURE SENSING

IPC classification:
A61M 5/48, A61M 31/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14734540

ANTI-MICROBIAL AGENTS AND USES THEREFOR

IPC classification:
A61K 38/47, C12N 9/46
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14816633

FUSED TRICYCLIC AMIDE COMPOUNDS AS MULTIPLE KINASE INHIBITORS

IPC classification:
A61K 31/4353, A61K 31/4427, A61K 31/506, A61K 31/519, A61P 35/00, C07D 213/60, C07D 401/04, C07D 401/12, C07D 405/12, C07D 413/12, C07D 471/04, C07D 471/12, C07D 487/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14818636

FUSED TRICYCLIC UREA COMPOUNDS AS RAF KINASE AND/OR RAF KINASE DIMER INHIBITORS

IPC classification:
A61K 31/4353, A61K 31/4427, A61K 31/506, A61K 31/519, A61P 35/00, C07D 213/60, C07D 401/04, C07D 401/12, C07D 405/12, C07D 413/12, C07D 471/04, C07D 471/12, C07D 487/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14741936

METHODS FOR TREATING CANCER

IPC classification:
A61K 39/395, A61K 48/00, A61P 35/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14750794

FORMULATIONS AND MATERIALS WITH CATIONIC POLYMERS

IPC classification:
A61K 6/083, A61L 24/00, A61L 27/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11787245

HETEROCYCLIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/42, A61K 31/44
Applicant:
Intellikine LLC
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14843998

METHOD FOR MEASURING INFLUENZA B VIRUS

IPC classification:
C07K 16/10, C12M 1/34, C12N 15/02, C12P 21/08, G01N 33/543, G01N 33/569, G01N 33/577
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14842085

ARYL ETHERS AND USES THEREOF

IPC classification:
A61K 31/085
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14844963

METHOD FOR MEASURING TYPE A INFLUENZA VIRUS

IPC classification:
C07K 16/10, G01N 33/543, G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14843481

SAMPLE PROCESSING METHOD FOR INFLUENZA VIRUS IMMUNOASSAY, AND IMMUNOASSAY METHOD

IPC classification:
G01N 33/543, G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12785822

THREE-DIMENSIONAL NET STRUCTURE, METHOD FOR PRODUCING THREE-DIMENSIONAL NET STRUCTURE, AND APPARATUS FOR PRODUCING THREE-DIMENSIONAL NET STRUCTURE

IPC classification:
D04H 3/16
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11749476

PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE

IPC classification:
A61K 31/5415, A61P 25/00, C07D 279/20
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11797398

METHOD OF TREATMENT

IPC classification:
A61K 9/107, A61K 38/40, A61P 13/12
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11842206

OVERHEATING DETECTION UNIT AND OXYGEN-CONCENTRATING DEVICE

IPC classification:
A61M 1/00, A61M 16/06, A61M 16/08, A61M 16/10, A61M 16/20, A61M 39/22, A61M 39/28, C01B 13/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14850964

INHIBITORS OF ERK AND METHODS OF USE

IPC classification:
A61K 31/415, A61K 31/495, C07D 471/14
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14809706

ANTIMICROBIAL COMPOUNDS

IPC classification:
A61K 31/04, A61K 31/166, A61K 31/167, A61P 31/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11809733

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/44, C12Q 1/60, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11819268

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/573, A61K 36/77, A61P 19/02, A61P 25/14, A61P 25/16, A61P 25/28, A61P 29/00, A61P 35/00, A61P 35/02, C07J 63/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167223

Timed, pulsatile release systems

IPC classification:
A61K 9/50
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14809200

HIGH YIELDING TOBACCO WITH ORIENTAL TOBACCO CHARACTERISTICS

IPC classification:
A24B 15/10
Applicant:
Altria Client Services Inc.
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14866032

IMMUNE MONITORING TO PREDICT AND PREVENT INFECTION

IPC classification:
G01N 33/50
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14867137

RATIONALE-BASED DESIGN OF A TARGETED THERAPY FOR CANCER

IPC classification:
A01N 43/00, A61K 31/00, C12Q 1/68
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15202691

ENGINEERED MICROBE-TARGETING MOLECULES AND USES THEREOF

IPC classification:
A61K 47/48, C07K 14/42, C07K 14/47, C07K 16/12, G01N 33/543, G01N 33/569
Applicant:
President and Fellows of Harvard College
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14868836

COMPOSITIONS AND METHODS FOR DETECTING RARE SEQUENCE VARIANTS

IPC classification:
C12Q 1/68, C40B 30/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Gemma Campabadal i Monfà, Wilson Sonsini Goodrich & Rosati LLP (WSGR)
Status:
EXAMINATION REQUESTED
EP14871152

CYCLIC SULFONE AND SULFOXIMINE ANALOGS AND USES THEREOF

IPC classification:
C07D 495/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14877922

FUSION POLYPEPTIDES AND METHODS OF USE

IPC classification:
C07K 14/555, C07K 19/00, C12N 1/21, C12N 15/24, C12N 15/62
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16171776

COMPOSITIONS AND METHODS FOR PREPARING SEQUENCING LIBRARIES

IPC classification:
C12Q 1/68, C40B 40/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15740988

METHODS OF PREPARING NUCLEIC ACIDS FOR SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
The General Hospital Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16175274

COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA

IPC classification:
A61K 38/04, A61K 39/012
Applicant:
The Board of Trustees of The University of Arkansas
Applicant:
Texas A&M University System (TAMU)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15755565

COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS

IPC classification:
A61P 3/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15710358

TOBACCO INBRED AND HYBRID PLANTS AND TOBACCO PRODUCTS MADE THEREOF

IPC classification:
A01H 5/12, A24B 15/10, C12N 9/02, C12N 9/10
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15709601

TOBACCO INBRED AND HYBRID PLANTS AND TOBACCO PRODUCTS MADE THEREOF

IPC classification:
A01H 5/12, A24B 13/00, A24B 13/02, C12N 9/10, C12N 15/82
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15709600

TOBACCO INBRED AND HYBRID PLANTS AND TOBACCO PRODUCTS MADE THEREOF

IPC classification:
A01H 5/12, A24B 13/00, A24B 13/02, C12N 9/10, C12N 15/82
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15709326

COMBINED USE OF A VECTOR ENCODING A MODIFIED RECEPTOR AND ITS EXOGENOUS AGONIST IN THE TREATMENT OF SEIZURES

IPC classification:
A61K 31/55, A61K 38/17, A61P 25/08, C12N 15/64
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15762448

METHOD FOR INDUCING PLURIPOTENCY IN A HEMATOPOIETIC CELL

IPC classification:
C12N 5/02, C12N 5/074, C12N 5/0789, C12N 5/10
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15766022

METHOD FOR PREDICTING TOXICITY OF A COMPOUND BASED ON NUCLEAR FACTOR-kB TRANSLOCATION

IPC classification:
C12Q 1/68, G01N 33/533, G01N 33/68
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15764279

IMMUNOGENIC GLYCOPEPTIDES, COMPOSITION COMPRISING THE GLYCOPEPTIDES AND USE THEREOF

IPC classification:
A01N 43/04, A61K 39/00, A61K 45/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15815127

TEXTURED INGESTIBLE PRODUCTS

IPC classification:
A01C 1/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15818471

VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ERBB2) AND METHODS OF USING THE SAME

IPC classification:
A61K 48/00, A61P 35/00, C07H 21/04
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15818810

VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME

IPC classification:
A61K 39/00, A61P 35/00, C07K 1/00
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15800453

CYTOKINE-CHITOSAN BIOCONJUGATES AND METHODS OF USING THE SAME

IPC classification:
A01N 43/04, A61K 31/715
Applicant:
The Board of Trustees of The University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15838538

IMPLANTABLE MESH AND METHOD OF USE

IPC classification:
A61B 17/00, A61F 2/00, A61L 31/00
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15840540

METHODS AND MATERIALS FOR PRODUCING FRUIT OF ALTERED SIZE

IPC classification:
A01H 4/00, A01H 5/08, C12N 15/05, C12N 15/82
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15838274

TOPICAL PTEROSTILBENE COMPOSITIONS FOR USE IN TREATING UV-INDUCED LOSS OF BARRIER FUNCTION IN SKIN

IPC classification:
A61Q 17/00
Applicant:
The Regents of the University of California
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15844508

COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA

IPC classification:
A61K 9/48
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15832008

HIGH-THROUGHPUT SAMPLE PROCESSING SYSTEMS AND METHODS OF USE

IPC classification:
B01L 3/02, B01L 7/00, B01L 99/00, C12Q 1/68, G01N 1/38, G01N 35/00, G01N 35/02, G01N 35/10
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature